Provectus Biopharmaceuticals Announces Joint Patent for Oncology Therapy PV-10

The patent, shared with Pfizer, covers PV-10 when used in combination with select melanoma and liver cancer therapies. Provectus hopes...

Provectus Pharmaceuticals Inc. and PV-10: Rose Bengal as a Novel Cancer Therapeutic

In this interview with The Life Sciences Report, Peter Culpepper, CFO and COO of Provectus Pharmaceuticals Inc., describes his company's...

Treatments Target Allergy Sufferers

As allergies become more common, Circassia and Stallergenes are making strides toward developing treatments.